ANDA 207945, held by Ezra Ventures. Fingolimod Hydrochloride.
As of Nov 16, 2026, ANDA 207945 (Fingolimod Hydrochloride), held by Ezra Ventures, was first approved by FDA on Dec 6, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 6, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fingolimod HydrochlorideEQ 0.5MG BASE ยท capsule;oral | Fingolimod Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters